Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
UrtesteWAR:URT -6.91%33 Forward Dividend Yield % is 0.00% as of Jul. 29, 2026. GuruFocus rates WAR:URT with a GF Score™ of 33/100 and a GF Value™ of zł284.41 (Possible Value Trap). The stock has 1 warning sign investors should review. Among 149 Biotechnology companies, Urteste ranks worse than 671140.27% on this metric.
As of today (2026-07-29), the Forward Annual Dividend Yield of Urteste is 0.00%.
As of today (2026-07-29), the Trailing Annual Dividend Yield of Urteste is 0.00%.
WAR:URT's Forward Dividend Yield % is not ranked *
in the Biotechnology industry.
Industry Median: 1.35 * Ranked among companies with meaningful Forward Dividend Yield % only.
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
WAR:URT vs VRTX, REGN, RVMD: Forward Dividend Yield % Comparison
For the Biotechnology subindustry, Urteste's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Urteste Forward Dividend Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Urteste's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Urteste's Forward Dividend Yield % falls into.
What does a Forward Dividend Yield % of 0.00% mean?
Urteste (WAR:URT) has a Forward Dividend Yield % of 0.00% as of Jul. 29, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Urteste and its competitors. According to the industry distribution chart, Urteste ranks #999999 out of 149 companies in the Biotechnology industry.
Is Urteste's Forward Dividend Yield % too high?
Urteste's current Forward Dividend Yield % is 0.00%. Based on the distribution chart, Urteste ranks #999999 out of 149 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Urteste has a GF Score™ of 33/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Urteste's Forward Dividend Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Urteste ranks #999999 out of 149 companies for Forward Dividend Yield %. This places Urteste in the lower half of its industry. The industry median Forward Dividend Yield % is 1.35. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Biotechnology company?
The median Forward Dividend Yield % among Biotechnology companies is 1.35, based on 149 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Urteste and its competitors. For the Biotechnology industry, the median Forward Dividend Yield % is 1.35 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Urteste's current Forward Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Urteste stock overvalued right now?
Based on GuruFocus' analysis, Urteste (WAR:URT) is currently considered Possible Value Trap. The stock's GF Value™ is zł284.41, compared to a current price of zł43.10 — trading 84.8% below its estimated fair value. The current Forward Dividend Yield % is 0.00%. Urteste's overall GF Score™ is 33/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Urteste (WAR:URT), the current Forward Dividend Yield % is 0.00% as of Jul. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Urteste (WAR:URT) Overvalued in 2026?
Based on GuruFocus' analysis, Urteste stock appears to be undervalued.
The current stock price of zł43.10 is trading 84.8% below its estimated GF Value™ of zł284.41.
GuruFocus considers Urteste to be Possible Value Trap.
Key valuation signals for WAR:URT:
Forward Dividend Yield %: 0.00%
GF Value™: zł284.41 vs. price of zł43.10 (84.8% below fair value)
No single metric tells the full story. See the WAR:URT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Urteste SA specialises in the development of technology allowing the detection of cancers at the early stages of their development. The companies technology helps detect cancers by measuring the activity of the enzymes in urine. Urteste develops diagnostic tests for more than ten common cancers.
33GF Score
Get the complete analysis for WAR:URT
Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:URT has been successfully added to your 
